Karen Johnson

Traditional advisory boards often struggle with physician availability, geography, and low participation. Explore how pharma can modernize these advisory boards by combining asynchronous engagement models with AI-driven insight generation. Source best practices on:

• Enabling flexible, broader participation while increasing cost efficiency and maintaining compliance rigor.
• Generating higher-quality, more actionable feedback from participants, while transforming this unstructured feedback into real-time, next-best recommendations and prioritized insights.
• Integrating asynchronous advisory outputs directly into commercialization and medical affairs workflows.

Develop your strategies for AI-enabled advisory engagement that accelerates insights, strengthens physician relationships, and drives more impactful, patient-centric outcomes for commercial and medical affairs teams.